Osaka has the science. Now it needs the business
Osaka has the science. Now it needs to build the companies, capital and global reach to turn that science into…
All articles by Catherine Longworth
Catherine Longworth
@MedtechCate
Catherine Longworth is Healthcare Editor-in-Chief at GlobalData, where she leads coverage of updates across pharma, biotech, medical technology, and health tech. With a background in biomedical science and journalism, she has reported on healthcare developments across multiple regions since 2016, bringing a global perspective to her work. Catherine has extensive experience leading B2B publications and is recognised for delivering insightful, accurate, and forward-looking reporting. She frequently moderates international industry panels and conferences, connecting audiences with thought leaders from around the world.
-
-
What is ‘Premium Content’ on Pharmaceutical Technology?
Pharmaceutical Technology has introduced new ‘Premium Content’ for its readers – here’s an explanation of what’s changing and what isn’t.…
-
Between two giants: Europe’s new oncology chapter takes shape in Paris
The opening of THE HIVE at Campus Grand Parc was marked not simply by the inauguration of a new laboratory…
-
Validation to velocity: Japan’s pharma model comes under execution pressure
Japan’s pharmaceutical industry - the world’s third largest by market value after the United States and China - has long…
-
Building for decades: Dubai’s long game in life sciences
Editor's note: This feature was reported in part prior to the escalation of hostilities in the Gulf, when Iran launched…
-
Women first: the Gulf’s new healthcare blueprint
Nabta Health, a Dubai-based women's health company, is up for a prestigious MedTech award, but its founder Sophie Smith has…
-
Estonia’s digital health DNA: Trust, data, and biotech in focus
With just 1.3 million residents, Estonia’s digital footprint far exceeds its size. When Barack Obama visited Tallinn in 2014, he…
-
Navigating regulatory change in APAC: Insights from the upcoming BioSecure Act Webinar
The regulatory landscape across the Asia-Pacific (APAC) region is evolving rapidly, and pharmaceutical companies must adapt to maintain compliance, mitigate…
-
Europe’s cannabis pharmaceuticals market matures amid cautious investment
Europe’s cannabis pharmaceutical market is far from a gold rush, yet it is emerging as one of the more strategic…
-
Synthetic rescue: Insmed explores a new frontier in genetic therapeutics
Nestled on the southern fringe of Cambridge within the Babraham Research Campus, US-based biopharma Insmed is laying the groundwork for…